Controversies in hypertension

Hypertension remains the most common risk factor for cardiovascular morbidity and mortality. Its incidence is rising in both ageing and obese populations, but its control remains inadequate worldwide. We address several persisting controversies that may interfere with appropriate management of hyper...

Full description

Saved in:
Bibliographic Details
Published in:The Lancet (British edition) 2006-01, Vol.367 (9505), p.168-176
Main Authors: Kaplan, Norman M, Opie, Lionel H
Format: Article
Language:English
Subjects:
Adult
Aged
Antihypertensive Agents - classification
Antihypertensive Agents - therapeutic use
Cardiovascular Diseases - etiology
Developing Countries
Diet
Exercise
Female
Humans
Hypertension - complications
Hypertension - drug therapy
Hypertension - etiology
Incidence
Life Style
Male
Middle Aged
Obesity - complications
Risk Factors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hypertension remains the most common risk factor for cardiovascular morbidity and mortality. Its incidence is rising in both ageing and obese populations, but its control remains inadequate worldwide. We address several persisting controversies that may interfere with appropriate management of hypertension. They include: the reasons behind the increasing incidence of hypertension and the possible ways to slow the process, especially by lifestyle changes; the need for overall cardiovascular risk assessment; the major issues in the decision to institute drug therapy and the choice of drugs; and the importance of screening for various identifiable causes. We provide the background for these controversies, followed by some opinions on how to guide practitioners to offer more effective management of hypertension.
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(06)67965-8